NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
12.24
+0.39 (3.25%)
Mar 31, 2025, 2:36 PM EDT - Market open
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $398.37 million as of March 31, 2025. Its market cap has increased by 5.04% in one year.
Market Cap
398.37M
Enterprise Value
406.42M
1-Year Change
5.04%
Ranking
Category
Stock Price
$12.24
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $398.37M, an increase of 1.30%. That is a compound annual growth rate of 0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 385.84M | 15.52% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |